12 hrs ago | Business Journal
New drug development for schizophrenia, next Marquette Presents topic
A top adult psychiatrist and the co-founders of two distinct pharmaceutical start-up companies from the Marquette University College of Health Sciences headline the next Marquette Presents forum: "Schizophrenia-New Hope for Effective Treatment Through Drug Development." The forum will take place in the third-floor ballroom of the Alumni memorial ... (more)
18 hrs ago | MediLexicon
Researchers Eliminate Schizophrenia Symptoms In An Animal Model
Overexpression of a gene associated with schizophrenia causes classic symptoms of the disorder that are reversed when gene expression returns to normal, scientists report.
Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease
OMS824 selectively inhibits phosphodiesterase 10 , an enzyme expressed in areas of the brain linked to a wide range of diseases that affect cognition, including Huntington's disease and schizophrenia.
Positive Trial Results for Otsuka Pharmaceutical Co., Ltd. and H....
Positive Trial Results for Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S 's Abilify Maintena in Schizophrenia Staying up-to-date has never been simpler.
A long-term, phase 2, multicenter, randomized, open-label,...
We compared the time to discontinuation due to lack of tolerability over 24 weeks in patients suffering from schizophrenia treated with pomaglumetad methionil or standard of care .
American Cancer Society Turns 100, Cancer Incidents in U.S. Trending Downward
In a bit of good news today, the American Cancer Society reports that as of Wednesday, its 100th birthday, two out of three people who are diagnosed with cancer today will survive for at least five years, and cancer rates in the U.S. are down 20 percent overall since the 1990s.
Schizophrenia symptoms eliminated in animal model
They genetically engineered mice so they could turn up levels of neuregulin-1 to mimic high levels found in some patients then return levels to normal, said Dr.
Taming suspect gene reverses schizophrenia-like abnormalities in mice
This image show, from left: Lin Mei, M.D., Ph.D., Dong-Min Yin, Ph.D. and Yong-Jun Chen, Ph.D., Medical College of Georgia.
Why Old Schizophrenia Medicine Works On Antibiotic-Resistant Bacteria
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia , is also a powerful weapon against antibiotic-resistant bacteria such as staphylococci .
Association Between Genetic Risk For Schizophrenia And Reduced IQ
The relationship between the heritable risk for schizophrenia and low intelligence has not been clear.
Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as staphylococci .
Genetic risk for schizophrenia is connected to reduced IQ
The relationship between the heritable risk for schizophrenia and low intelligence has not been clear.
Aripiprazole belongs to the group of medications known as antipsychotics . It is used to treat schizophrenia and bipolar disorder.
Australian Broadcasting Corporation
Researchers say schizophrenia needs to be approached like other physical illnesses, and what is needed is early intervention and tailored, targeted treatments.
Deaths reported in children prescribed "newer generation" antipsychotics
Once reserved for schizophrenia and mania in adults, the drugs are increasingly being prescribed to children as young as preschoolers.
Hypertension Drug Appears to Relieve Psychosis
Patients experiencing psychosis quickly improved after a single infusion of sodium nitroprusside, an antihypertensive agent, according to a new study published in JAMA Psychiatry .
Anti-hypertension drug may improve schizophrenia symptoms
An anti-hypertension drug administered intravenously for a single four-hour treatment resulted in dramatic improvements of symptoms for people living with schizophrenia, according to newly published findings from clinician scientists at the University of Alberta's medical school and their colleagues in Brazil.
Why Psychiatry's Seismic Shift Will Happen Slowly
Last week, Thomas Insel, Director of the National Institute of Mental Health, published a blog post that outlined a new approach for deciding what psychiatry research the U.S. government would fund.
Gardening comfort tips for boomers
Researcher at the Tel Aviv University in Israel may have found a way to diagnose schizophrenia by testing microRNA molecules in neurons from the nose.
Lilly CEO to undergo surgery, CFO Rice to become interim CEO
Lilly Chief Financial Officer Derica Rice, 48, will assume the additional role of acting CEO during Lechleiter's surgery and recovery period, the Indianapolis drugmaker said.